Product correctly added to cart.

discount label
Vioxx-d5 (major)
View 3D

Biosynth logo

Vioxx-d5 (major)

CAS: 544684-93-7

Ref. 3D-UWA68493

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Tuesday 18 Feb 2025

Product Information

Name:
Vioxx-d5 (major)
Controlled Product
Description:

Rofecoxib is a non-steroidal anti-inflammatory drug (NSAID) that belongs to the coxib class of drugs. It is used for the relief of pain, inflammation, and stiffness associated with osteoarthritis and rheumatoid arthritis. Rofecoxib inhibits cyclooxygenase-2 (COX-2), which is responsible for making prostaglandins. COX-2 inhibitors are also used as an analgesic in cancer patients and those with chronic inflammatory diseases. Celecoxib is another NSAID that belongs to the coxib class of drugs. It has been shown to be effective in treating pain and inflammation in osteoarthritis and rheumatoid arthritis patients. These drugs may have long-term toxicity effects, such as increased risk of cancer or other diseases, but more research needs to be done before these conclusions can be made.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
314.4 g/mol
Formula:
C17H14O4S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-UWA68493 Vioxx-d5 (major)

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".